Francis X. Sullivan - Jan 1, 2023 Form 3 Insider Report for PPL Corp (PPL)

Signature
/s/ W. Eric Marr, as Attorney-In-Fact for Francis X. Sullivan
Stock symbol
PPL
Transactions as of
Jan 1, 2023
Transactions value $
$0
Form type
3
Date filed
1/9/2023, 03:34 PM
Next filing
Jan 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PPL Common Stock 0 Jan 1, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PPL Stock Unit (ICPKE) Jan 1, 2023 Common Stock 233 Direct F1, F2
holding PPL Stock Unit (ICPKE) Jan 1, 2023 Common Stock 913 Direct F2, F3
holding PPL Performance Unit (ICPKE) Jan 1, 2023 Common Stock 486 Direct F4, F5
holding PPL Performance Unit (ICPKE) Jan 1, 2023 Common Stock 486 Direct F5, F6
holding PPL Performance Unit (ICPKE) Jan 1, 2023 Common Stock 942 Direct F5, F7
holding PPL Performance Unit (ICPKE) Jan 1, 2023 Common Stock 942 Direct F5, F8
holding PPL Performance Unit (ICPKE) Jan 1, 2023 Common Stock 1.88K Direct F5, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The units will vest on 10/01/2024.
F2 No conversion or exercise price applies. Under the terms of the Incentive Compensation Plan for Key Employees (ICPKE), a restricted stock unit converts to a share of common stock on the applicable vesting date.
F3 The units will vest on 01/27/2025.
F4 No conversion or exercise price or exercise or expiration date applies. Under the terms of the Incentive Compensation Plan for Key Employees (ICPKE), all, some or none of the underlying securities will be earned depending on the Company's performance relative to an industry peer group over a three-year performance period ending 12/31/2023. Determination of number of underlying securities that have been earned, if any, will be made by the Compensation Committee in January 2024.
F5 Total includes the reinvestment of dividends.
F6 No conversion or exercise price or exercise or expiration date applies. Under the terms of the Incentive Compensation Plan for Key Employees (ICPKE), all, some or none of the underlying securities will be earned depending on the Company's return on equity over a one-year performance period ending 12/31/2021, but will not vest, if at all, until the end of the three-year period ending 12/31/2023. Determination of number of underlying securities that have been earned, if any, will be made by the Compensation Committee in January 2024.
F7 No conversion or exercise price or exercise or expiration date applies. Under the terms of the Incentive Compensation Plan for Key Employees (ICPKE), all, some or none of the underlying securities will be earned depending on the Company's earnings growth over a three-year performance period ending 12/31/2024. Determination of number of underlying securities that have been earned, if any, will be made by the Compensation Committee in January 2025
F8 No conversion or exercise price or exercise or expiration date applies. Under the terms of the Incentive Compensation Plan for Key Employees (ICPKE), all, some or none of the underlying securities will be earned depending on the Company's achievement of certain ESG-related metrics over a three-year performance period ending 12/31/2024. Determination of number of underlying securities that have been earned, if any, will be made by the Compensation Committee in January 2025
F9 No conversion or exercise price or exercise or expiration date applies. Under the terms of the Incentive Compensation Plan for Key Employees (ICPKE), all, some or none of the underlying securities will be earned depending on the Company's performance relative to an industry peer group over a three-year performance period ending 12/31/2024. Determination of number of underlying securities that have been earned, if any, will be made by the Compensation Committee in January 2025.